http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106124763-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_351a93599f7824f58f1741785ea55347 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N27-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N24-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N24-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2016-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_945dfbf2034d0342ada3e6f2cf12537f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8776f86c5c803f7ddb411f82799f0b7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81e042b77f5ab0f87d6f1af085f1b230 |
publicationDate | 2016-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106124763-A |
titleOfInvention | For diagnosing the biomarker combinations thing of cervicitis and cervical cancer |
abstract | The invention discloses biomarker combinations thing, wherein, for diagnosing the biomarker combinations thing of cervicitis and cervical cancer, it is characterised in that at least include one or more the combination of 5' uridine monophosphate disodium, histamine, 3' methoxyl group guanosine, phenyl-lactic acid.For diagnosing the biomarker combinations thing of cervicitis, it is characterized in that, including: one or more the combination of 5' uridine monophosphate disodium, L cysteine, 1-Hydroxy-1,2,3-propanetricarboxylic acid., uridine diphosphate glucose, adenosine monophosphate, trophicardyl 5' monophosphate, L pipecoliacid, N acetyl putrescine, sucrose.Biomarker combinations thing for diagnosing cervical, it is characterised in that including: one or more combination of histamine, phenyl-lactic acid, citraconic acid, L 2 aminoadipic acid, 3'O methoxyl group guanosine, β D glucamine, glycerol, cholesterol sulfate. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7018605-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108196052-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018169376-A |
priorityDate | 2016-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.